EYES

Second Sight Medical Products, Inc. [EYES] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

EYES Stock Summary

In the News

EYES Financial details

Company Rating
-
Market Cap
210.05M
Income
-9.08M
Revenue
260K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
04 Jul 2022
P/E
-10.28
Forward P/E
-
PEG
1.53
P/S
-
P/B
0.86
P/C
-
P/FCF
-40.28
Quick Ratio
21.76
Current Ratio
22.15
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.71
EPS next Y
-
EPS next Q
-
EPS this Y
-62.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-42.14%
Revenue last 5Y
NAN%
Revenue Q/Q
-
EPS Q/Q
35.29%
-
-
-
-
SMA20
-3.33%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-8%
ROE
-8%
ROC
-0.08%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
-
52W High
-
52W Low
-
RSI
50
Rel Volume
-
Avg Volume
-
Volume
512
Perf Week
-2.1%
Perf Month
5.07%
Perf Quarter
-
Perf Half Y
574.15%
-
-
-
-
Beta
2.55714
-
-
Volatility
0.51%, 0.67%
Prev Close
-0.68%
Price
27.91
Change
-0.71%

Something similar

Top by Market Cap
M&M.NS
VOO
GOOG
GOOGL
FB2A.DE
Same Sector
CSLT
1099.HK
PXS.L
SSMXY
ELIC.ST
Check Those
TXP.TO
MNT.TO
TIL.NS
2283.HK
POW
Similar Market Cap
OGI
OBIL
SFR.L
GPRO
PMF

Company Profile

Healthcare Medical - Devices
  • Market Capitalization 210.05M
  • Employee 15
  • CEO Mr. Matthew Pfeffer
  • Headquarters Sylmar,CALIFORNIA,US
  • IPO Date 2014-11-19
  • Website https://www.secondsight.com

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.